IN2014MU00193A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MU00193A IN2014MU00193A IN193MU2014A IN2014MU00193A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A IN 193MU2014 A IN193MU2014 A IN 193MU2014A IN 2014MU00193 A IN2014MU00193 A IN 2014MU00193A
- Authority
- IN
- India
- Prior art keywords
- acceptable derivative
- pharmaceutical
- doripenem
- ertapenem
- meropenem
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES15708275T ES2804500T3 (es) | 2014-01-21 | 2015-01-20 | Composiciones farmacéuticas que comprenden agentes antibacterianos |
| CA2954553A CA2954553C (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| US15/323,631 US10322116B2 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| PCT/IB2015/050421 WO2015110950A1 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| BR112017003444-1A BR112017003444B1 (pt) | 2014-01-21 | 2015-01-20 | Composições farmacêuticas compreendendo ertapenem e um composto de fórmula (i) |
| NZ728036A NZ728036A (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| EP15708275.1A EP3217979B8 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| IN193MU2014 IN2014MU00193A (enExample) | 2014-01-21 | 2015-01-20 | |
| RU2017110457A RU2705375C2 (ru) | 2014-01-21 | 2015-01-20 | Фармацевтические композиции, содержащие антибактериальные агенты |
| AU2015208830A AU2015208830A1 (en) | 2014-01-21 | 2015-01-20 | Pharmaceutical compositions comprising antibacterial agents |
| ZA2017/00064A ZA201700064B (en) | 2014-01-21 | 2017-01-04 | Pharmaceutical compositions comprising antibacterial agents |
| US15/846,929 US20180104224A1 (en) | 2014-01-21 | 2017-12-19 | Pharmaceutical compositions comprising antibacterial agents |
| AU2020201956A AU2020201956B2 (en) | 2014-01-21 | 2020-03-18 | Pharmaceutical compositions comprising antibacterial agents |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN193MU2014 IN2014MU00193A (enExample) | 2014-01-21 | 2015-01-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU00193A true IN2014MU00193A (enExample) | 2015-08-28 |
Family
ID=52629621
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN193MU2014 IN2014MU00193A (enExample) | 2014-01-21 | 2015-01-20 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10322116B2 (enExample) |
| EP (1) | EP3217979B8 (enExample) |
| AU (2) | AU2015208830A1 (enExample) |
| CA (1) | CA2954553C (enExample) |
| ES (1) | ES2804500T3 (enExample) |
| IN (1) | IN2014MU00193A (enExample) |
| NZ (1) | NZ728036A (enExample) |
| RU (1) | RU2705375C2 (enExample) |
| WO (1) | WO2015110950A1 (enExample) |
| ZA (1) | ZA201700064B (enExample) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100278921A1 (en) * | 2009-04-30 | 2010-11-04 | Fischer Cristina M | Solid oral formulation of abt-263 |
| PT2748165T (pt) * | 2011-08-27 | 2016-12-28 | Wockhardt Ltd | Derivados de 1,6-diazabiciclo[3,2,1]octano-7-ona e sua utilização no tratamento de infeções bacterianas |
| US8796257B2 (en) | 2011-12-02 | 2014-08-05 | Naeja Pharmaceutical Inc. | Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors |
| AR091222A1 (es) * | 2012-05-30 | 2015-01-21 | Meiji Seika Pharma Co Ltd | INHIBIDOR DE b-LACTAMASA Y PROCESO PARA PREPARARLO |
| CN104884092A (zh) * | 2013-01-14 | 2015-09-02 | 沃克哈特有限公司 | 用于治疗细菌感染的组合物和方法 |
| RU2509560C1 (ru) * | 2013-03-22 | 2014-03-20 | Общество С Ограниченной Ответственностью "Валента-Интеллект" | Новые терапевтические комбинации миртазапина для применения при болевых расстройствах |
-
2015
- 2015-01-20 IN IN193MU2014 patent/IN2014MU00193A/en unknown
- 2015-01-20 EP EP15708275.1A patent/EP3217979B8/en active Active
- 2015-01-20 WO PCT/IB2015/050421 patent/WO2015110950A1/en not_active Ceased
- 2015-01-20 US US15/323,631 patent/US10322116B2/en active Active
- 2015-01-20 CA CA2954553A patent/CA2954553C/en active Active
- 2015-01-20 NZ NZ728036A patent/NZ728036A/en not_active IP Right Cessation
- 2015-01-20 RU RU2017110457A patent/RU2705375C2/ru active
- 2015-01-20 ES ES15708275T patent/ES2804500T3/es active Active
- 2015-01-20 AU AU2015208830A patent/AU2015208830A1/en not_active Abandoned
-
2017
- 2017-01-04 ZA ZA2017/00064A patent/ZA201700064B/en unknown
- 2017-12-19 US US15/846,929 patent/US20180104224A1/en not_active Abandoned
-
2020
- 2020-03-18 AU AU2020201956A patent/AU2020201956B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20170202813A1 (en) | 2017-07-20 |
| EP3217979B1 (en) | 2020-04-08 |
| BR112017003444A2 (pt) | 2023-03-07 |
| US20180104224A1 (en) | 2018-04-19 |
| RU2017110457A (ru) | 2018-10-03 |
| WO2015110950A1 (en) | 2015-07-30 |
| AU2020201956A1 (en) | 2020-04-02 |
| CA2954553A1 (en) | 2015-07-30 |
| AU2015208830A1 (en) | 2017-04-27 |
| ZA201700064B (en) | 2018-08-29 |
| AU2020201956B2 (en) | 2020-07-09 |
| EP3217979B8 (en) | 2020-06-03 |
| ES2804500T3 (es) | 2021-02-08 |
| CA2954553C (en) | 2022-12-06 |
| NZ728036A (en) | 2019-12-20 |
| RU2017110457A3 (enExample) | 2018-10-03 |
| EP3217979A1 (en) | 2017-09-20 |
| RU2705375C2 (ru) | 2019-11-07 |
| US10322116B2 (en) | 2019-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4071149A3 (en) | Heterocyclic compounds and uses thereof | |
| MD20160118A2 (ro) | Derivaţi ai pirolidin-2,5-dionei, compoziţii farmaceutice şi metode de utilizare ca inhibitori ai IDO1 | |
| AU2015336400A8 (en) | Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof | |
| GEP20207074B (en) | New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| EP3253382A4 (en) | Pharmaceutical compositions for combination therapy | |
| MX2016013431A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2018014813A (es) | Composiciones antibacterianas. | |
| EP3613419A4 (en) | PHARMACEUTICAL COMPOSITION WITH INDIRUBY DERIVATIVE AS THE ACTIVE SUBSTANCE | |
| HK1231390A1 (zh) | 用於局部给药的药用组合物 | |
| PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
| EP3290037A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| MX2016005160A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| IN2014MU00859A (enExample) | ||
| EP3960241A4 (en) | THERAPEUTIC AGENT FOR FLAVIVIRUS INFECTION | |
| EP3914234A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| MX2016013428A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| MX2016005539A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| NZ719215A (en) | Pharmaceutical compositions comprising antibacterial agents | |
| IN2014MU00193A (enExample) | ||
| IN2013MU03421A (enExample) | ||
| MX2017010992A (es) | Composiciones farmaceuticas estables que comprenden agente antibacteriano. | |
| MX2016012646A (es) | Composiciones farmaceuticas que comprenden agentes antibacterianos. | |
| EP3970805A4 (en) | ADDITIVE FOR MEDICINAL AGENTS | |
| GB202203127D0 (en) | Aerosolised formulation | |
| HK40079778A (en) | Pharmaceutical compositions |